Advanced Search


Study ID Status Title Patient Level Data
113949 Completed A partially blind study to evaluate the safety, reactogenicity and immunogenicity of GSK Biologicals’ Staphylococcal 4-component investigational vaccine (GSK2392102A) in healthy adults
113950 Completed A Single-Centre, Randomised, Open-label Study to Evaluate the Effects of Steady-State Verapamil, a Moderate P-Glycoprotein and CYP3A4 Inhibitor, on the Pharmacokinetics of GSK573719 and GSK573719 in Combination with GW642444 Study Listed on
113951 Completed Korean’s practice patterns for screening PCA(prostate cancer) according to PSA(prostate-specific antigen) level
113954 Completed Antibody persistence and immune memory against the hepatitis B antigen in 11-12 year old children, previously vaccinated with DTPa-HBV-IPV/Hib vaccine in study 217744/031 Study Listed on
113960 Terminated Clinical Outcomes on ErbB2+ MBC patients treated with Lapatinib-Capecitabine after Trastuzumab Progression: Role of early versus late switch to Lapatinib-Capecitabine (TYCO1) - Brazil
113962 Completed Risk of hemorrhage in patients prescribed Arixtra compared to LMWH
113970 Completed An open-label, non-randomized pharmacokinetic and safety study of repeat doses of fluticasone furoate and GW642444M combination in healthy subjects and in subjects with severe renal impairment. Study Listed on
113971 Completed An Open-Label Study to Evaluate the Effects of Ketoconazole and the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Repeat Doses of Pazopanib in Subjects with Solid Tumor Malignancies
113973 Completed A retrospective cohort study to evaluate the rate of good responses to lamivudine (LAM) treatment in naïve Chronic Hepatitis B (CHB) patients with certain pre-treatment characteristics
113977 Completed Persistence of antibodies after vaccination with a dose of GSK Biologicals’ meningococcal vaccine GSK134612 in healthy children and safety and immunogenicity of a booster dose at 68 months post-primary vaccination
113978 Completed Immunogenicity and safety study of GlaxoSmithKline Biologicals’ GSK2202083A vaccine administered as a booster dose in 12-18 months old healthy children Study Listed on
113979 Completed Economic Analyses Alongside the REDUCE Clinical Trial
113984 Completed Dutasteride in Enlarged Prostate economic assessment: A retrospective database pooled analysis of early 5-alpha reductase inhibitor use
113985 Completed AVANDIA® (rosiglitazone maleate) 2009 Update to Integrated Cardiovascular (CV) Endpoint data from the Final Analyses for Studies BRL-049653/048 (ADOPT), AVD107642 (DREAM), and BRL-049653/231 (RECORD).
113989 Completed A Long-term Study to Evaluate the Safety and Tolerability of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and FF Inhalation Powder in Japanese Subjects with asthma Study Listed on
113994 Completed Safety, reactogenicity & immunogenicity of GSK Biologicals’ pneumococcal vaccine 2189242A when co-administered with DTPa-HBV-IPV/Hib vaccine in healthy infants
114000 Completed A study to evaluate the safety and efficacy of A/California/7/2009 (H1N1)v-like vaccines GSK2340274A and GSK2340273A in children aged 6 months to less than 10 years of age Study Listed on
114001 Completed Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan Africa
114002 Completed proportion of ocular symptoms in patients with allergic rhinitis in Korea
114005 Completed A Phase 1, Open Label, Single Sequence, Three Period Study to Evaluate the Single Dose Pharmacokinetics of GSK1349572 100mg versus 50mg and the Effect of Efavirenz 600mg Once Daily on the Pharmacokinetics, Safety and Tolerability of GSK1349572 50mg Once Daily in Healthy Adult Subjects (ING114005)
114009 Completed A Phase I study to evaluate single and multiple (seven) oral doses of SRT2104 on the endotoxin induced inflammatory response in healthy male subjects Study Listed on
114010 Completed A Phase IIa, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Assess the Safety, Tolerability, and Activity of Oral SRT2104 Capsules Administered for 28 Days to Subjects with Type 2 Diabetes Mellitus Study Listed on
114011 Completed A Phase I Randomized, Placebo-Controlled, Single-Blind, Multiple-Dose, Dose-Escalation Clinical Study to Assess the Safety and Pharmacokinetics of SRT2379 in Normal Healthy Male Volunteers Study Listed on
114012 Completed A Study to Evaluate Efficacy and Safety of Pazopanib Monotherapy in Asian women who have not progressed after first-line chemotherapy for advanced ovarian, fallopian tube or primary peritoneal carcinoma – An extension study to VEG110655
114013 Completed Systematic review of the clinical and cost effectiveness of treatments for idiopathic (immune) thrombocytopenic purpura (ITP): direct meta analysis



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.